261 related articles for article (PubMed ID: 21750347)
1. Adverse outcome pathways during early fish development: a conceptual framework for identification of chemical screening and prioritization strategies.
Volz DC; Belanger S; Embry M; Padilla S; Sanderson H; Schirmer K; Scholz S; Villeneuve D
Toxicol Sci; 2011 Oct; 123(2):349-58. PubMed ID: 21750347
[TBL] [Abstract][Full Text] [Related]
2. Comparative Assessment of the Sensitivity of Fish Early-Life Stage, Daphnia, and Algae Tests to the Chronic Ecotoxicity of Xenobiotics: Perspectives for Alternatives to Animal Testing.
Teixidó E; Leuthold D; de Crozé N; Léonard M; Scholz S
Environ Toxicol Chem; 2020 Jan; 39(1):30-41. PubMed ID: 31598995
[TBL] [Abstract][Full Text] [Related]
3. Investigating alternatives to the fish early-life stage test: a strategy for discovering and annotating adverse outcome pathways for early fish development.
Villeneuve D; Volz DC; Embry MR; Ankley GT; Belanger SE; Léonard M; Schirmer K; Tanguay R; Truong L; Wehmas L
Environ Toxicol Chem; 2014 Jan; 33(1):158-69. PubMed ID: 24115264
[TBL] [Abstract][Full Text] [Related]
4. Environmental effect assessment for sexual endocrine-disrupting chemicals: Fish testing strategy.
Knacker T; Boettcher M; Frische T; Rufli H; Stolzenberg HC; Teigeler M; Zok S; Braunbeck T; Schäfers C
Integr Environ Assess Manag; 2010 Oct; 6(4):653-62. PubMed ID: 20872646
[TBL] [Abstract][Full Text] [Related]
5. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
Kavlock R; Dix D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the integrated testing strategy for PNEC derivation under REACH.
May M; Drost W; Germer S; Juffernholz T; Hahn S
Regul Toxicol Pharmacol; 2016 Jul; 78():59-65. PubMed ID: 27103318
[TBL] [Abstract][Full Text] [Related]
7. Promoting the 3Rs to enhance the OECD fish toxicity testing framework.
Hutchinson TH; Wheeler JR; Gourmelon A; Burden N
Regul Toxicol Pharmacol; 2016 Apr; 76():231-3. PubMed ID: 26873775
[TBL] [Abstract][Full Text] [Related]
8. The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research.
Embry MR; Belanger SE; Braunbeck TA; Galay-Burgos M; Halder M; Hinton DE; Léonard MA; Lillicrap A; Norberg-King T; Whale G
Aquat Toxicol; 2010 Apr; 97(2):79-87. PubMed ID: 20061034
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of fish early life stage tests for predicting reproductive and longer-term toxicity from plant protection product active substances.
Wheeler JR; Maynard SK; Crane M
Environ Toxicol Chem; 2014 Aug; 33(8):1874-8. PubMed ID: 24799351
[TBL] [Abstract][Full Text] [Related]
10. Prioritizing chemicals of ecological concern in Great Lakes tributaries using high-throughput screening data and adverse outcome pathways.
Corsi SR; De Cicco LA; Villeneuve DL; Blackwell BR; Fay KA; Ankley GT; Baldwin AK
Sci Total Environ; 2019 Oct; 686():995-1009. PubMed ID: 31412529
[TBL] [Abstract][Full Text] [Related]
11. A strategy to reduce the use of fish in acute ecotoxicity testing of new chemical substances notified in the European Union.
Jeram S; Sintes JM; Halder M; Fentanes JB; Sokull-Klüttgen B; Hutchinson TH
Regul Toxicol Pharmacol; 2005 Jul; 42(2):218-24. PubMed ID: 15949882
[TBL] [Abstract][Full Text] [Related]
12. Multi-criteria decision analysis of test endpoints for detecting the effects of endocrine active substances in fish full life cycle tests.
Crane M; Gross M; Matthiessen P; Ankley GT; Axford S; Bjerregaard P; Brown R; Chapman P; Dorgeloh M; Galay-Burgos M; Green J; Hazlerigg C; Janssen J; Lorenzen K; Parrott J; Rufli H; Schäfers C; Seki M; Stolzenberg HC; van der Hoeven N; Vethaak D; Winfield IJ; Zok S; Wheeler J
Integr Environ Assess Manag; 2010 Jul; 6(3):378-89. PubMed ID: 20821701
[TBL] [Abstract][Full Text] [Related]
13. A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment.
Scholz S; Sela E; Blaha L; Braunbeck T; Galay-Burgos M; García-Franco M; Guinea J; Klüver N; Schirmer K; Tanneberger K; Tobor-Kapłon M; Witters H; Belanger S; Benfenati E; Creton S; Cronin MT; Eggen RI; Embry M; Ekman D; Gourmelon A; Halder M; Hardy B; Hartung T; Hubesch B; Jungmann D; Lampi MA; Lee L; Léonard M; Küster E; Lillicrap A; Luckenbach T; Murk AJ; Navas JM; Peijnenburg W; Repetto G; Salinas E; Schüürmann G; Spielmann H; Tollefsen KE; Walter-Rohde S; Whale G; Wheeler JR; Winter MJ
Regul Toxicol Pharmacol; 2013 Dec; 67(3):506-30. PubMed ID: 24161465
[TBL] [Abstract][Full Text] [Related]
14. Differentiating Pathway-Specific From Nonspecific Effects in High-Throughput Toxicity Data: A Foundation for Prioritizing Adverse Outcome Pathway Development.
Fay KA; Villeneuve DL; Swintek J; Edwards SW; Nelms MD; Blackwell BR; Ankley GT
Toxicol Sci; 2018 Jun; 163(2):500-515. PubMed ID: 29529260
[TBL] [Abstract][Full Text] [Related]
15. Chemical testing strategies for predicting health hazards to children.
Lamb JC; Brown SM
Reprod Toxicol; 2000; 14(2):83-94. PubMed ID: 10825671
[TBL] [Abstract][Full Text] [Related]
16. Chemical hazard prediction and hypothesis testing using quantitative adverse outcome pathways.
Perkins EJ; Gayen K; Shoemaker JE; Antczak P; Burgoon L; Falciani F; Gutsell S; Hodges G; Kienzler A; Knapen D; McBride M; Willett C; Doyle FJ; Garcia-Reyero N
ALTEX; 2019; 36(1):91-102. PubMed ID: 30332685
[TBL] [Abstract][Full Text] [Related]
17. Economic benefits of using adaptive predictive models of reproductive toxicity in the context of a tiered testing program.
Martin MT; Knudsen TB; Judson RS; Kavlock RJ; Dix DJ
Syst Biol Reprod Med; 2012 Feb; 58(1):3-9. PubMed ID: 22239076
[TBL] [Abstract][Full Text] [Related]
18. Human health screening level risk assessments of tertiary-butyl acetate (TBAC): calculated acute and chronic reference concentration (RfC) and Hazard Quotient (HQ) values based on toxicity and exposure scenario evaluations.
Bus JS; Banton MI; Faber WD; Kirman CR; McGregor DB; Pourreau DB
Crit Rev Toxicol; 2015 Feb; 45(2):142-71. PubMed ID: 25629921
[TBL] [Abstract][Full Text] [Related]
19. Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).
Tollefsen KE; Scholz S; Cronin MT; Edwards SW; de Knecht J; Crofton K; Garcia-Reyero N; Hartung T; Worth A; Patlewicz G
Regul Toxicol Pharmacol; 2014 Dec; 70(3):629-40. PubMed ID: 25261300
[TBL] [Abstract][Full Text] [Related]
20. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
